SC Immunotherapy: Rate and Severity of Reactions in Elderly – Monthly Prescribing Reference (registration)
|
SC Immunotherapy: Rate and Severity of Reactions in Elderly
Monthly Prescribing Reference (registration) ATLANTA, GA—Subcutaneous immunotherapy (SCIT) appears to be safe among elderly people, who experienced fewer and less severe reactions compared to adult and pediatric populations, according to findings of a retrospective analysis presented at the … Number of systemic reactions to SCIT declining, but severity increasing |
